|
Journal Papers, Abstracts,
and Commentaries
|
| |
In utero exposure to tenofovir disoproxil fumarate does not impair
growth and bone health in HIV-uninfected
children born to HIV-infected mothers.
Viganò A, Mora S, Giacomet V, et al
Antivir Ther.
2011;16(8):1259-66
Abstract
Pregnancy-Related effects on Tenofovir
Pharmacokinetics: A Population Study with 186 women.
Benaboud S,
Hirt D, Launay O,
et
al
Antimicrob Agents Chemother.
2011 Nov 28.
Abstract
Plasma and intracellular tenofovir pharmacokinetics in
the neonate (ANRS 12109 - Step 2).
Hirt D, Ekouévi DK, Pruvost A,
et
al
Antimicrob Agents Chemother.
2011 Apr 4.
Abstract
A WEEK-IN-REVIEW FEATURED REPORT
Tenofovir disoproxil fumarate in pregnancy and prevention of
mother-to-child transmission of HIV-1:
is it time to move on from zidovudine?
Foster C, Lyall H, Olmscheid B, et al
HIV Med. 2009 May 11.
Abstract |
Adverse effects of tenofovir use in HIV-infected pregnant women and
their infants.
Nurutdinova D, Onen NF, Hayes E, et al
Ann Pharmacother. 2008 Nov;42(11):1581-5.
Abstract
|
|
| |
6th IAS Conference
|
POSTER
Key considerations for successful implementation of the 2010 PMTCT
guidelines in Rwanda - tenofovir (TDF) based highly active antiretroviral
treatment (HAART) extended during breastfeeding regimens in Rwanda
I. Ange Anitha, S.U. Nadine, N. Jean Pierre, et al
Poster
Abstract |
18th CROI
Renal
Insufficiency Risk among HIV+, ART-naïve Individuals in Lilongwe,
Malawi: Implications for TDF
Use in ART and PMTCT Programs
D Johnson C Chasela, M Maliwichi,
et al
Abstract
11th Int Wkshop on Clin Pharm of HIV
|
Tenofovir population pharmacokinetics in HIV-infected children and adolescents
J. King, R. Yogev, A. Wiznia, et al
PDF Abstract |
17th CROI
|
POSTER
Exposure during Gestation to HAART,
Including Tenofovir, Does Not Impair Bone Status
and Metabolism in HIV- Children Born to HIV+ Mothers.
A Vigano, G V Zuccott, S Stucchi, et al
PDF Poster
Abstract
Tenofovir
Therapy during Pregnancy Does not Affect Renal Function in HIV-exposed Children
R Linde, C Königs, E Rusicke,
et al
Abstract
|
POSTER
Single-dose Tenofovir Disoproxil Fumarate
with and without Emtricitabine in HIV-1-infected Pregnant
Women
and Their Infants: Pharmacokinetics and Safety
P Flynn,
M Mirochnick, D Shapiro, et al
PDF Poster
Abstract
|
POSTER
Pharmacokinetics of Tenofovir Disoproxil
Fumarate after Administration to HIV-1-infected Pregnant
Women and
Their Newborns
M
Mirochnick, G Kafulafula, R Kreitchmann, et al
PDF Poster
Abstract
|
POSTER
Pharmacokinetics and Safety of
Tenofovir Disoproxil Fumarate in
HIV-1-infected Pregnant
Women and their Infants
J
Rodman, P Flynn, D Shapiro, et al
(13
CROI)
PDF Poster
Abstract |
|
Tenofovir Main Page
Main
New/Newsworthy
